Global IV Cannula Market - 2025-2033

The global IV cannula market reached US$ 45.9 million in 2024 and is expected to reach US$ 74.7 million by 2033, growing at a CAGR of 5.6% during the forecast period 2025-2033.

An IV cannula, also known as an intravenous cannula, is a medical device used to provide access to a patient's vein for the purpose of administering fluids, medications or drawing blood. It is a small, flexible tube typically inserted into the vein through a needle, which is then removed, leaving the cannula in place to allow ongoing access. It is designed for short- to medium-term use and must be handled with care to prevent complications.

The IV cannula market is growing steadily due to various factors such as the increasing prevalence of chronic diseases, rising surgical procedures, advancements in healthcare infrastructure and expanding home healthcare services. The shift towards home healthcare and outpatient care has increased the demand for IV cannulas, as many patients now receive treatments like antibiotics, chemotherapy, or hydration therapy at home. This has led to a rise in demand for easy-to-use, safe, and reliable IV access systems. For instance, the American Society of Clinical Oncology (ASCO) reports that over 1.8 million new cancer cases are diagnosed annually in the U.S., and many of these patients will require home-based IV chemotherapy infusions, contributing to the rising demand for IV cannulas in home healthcare.

Market Dynamics: Drivers & Restraints

Rising number of surgical procedures

The rising number of surgical procedures is significantly driving the growth of the IV cannula market and is expected to drive the market over the forecast period. Their primary use is for providing fluid administration, medication delivery, anesthesia, and blood transfusion during surgeries. With advancements in medical technology, the global number of both elective and emergency surgeries has increased. These procedures require IV access for various purposes such as anesthesia, fluid management, and medication administration.

For instance, according to the National Institute of Health (NIH), globally, over 310 million major surgeries are performed every year, in this, around 40 to 50 million surgeries are performed in USA and 20 million surgeries are performed in Europe. This rising number of surgical procedures highlights a continuous demand for IV cannulas in hospitals and surgical centers.

The rise in the variety of surgical specialties such as cardiac surgeries, oncological surgeries, orthopedic surgeries, plastic surgeries and neurosurgeries necessitates specialized IV access devices, including those with advanced features like safety systems or small gauges for delicate procedures. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a higher increase of 5.5% in surgical procedures, with more than 15.8 million procedures performed by plastic surgeons and 19.1 non-surgical procedures. Over the last four years, the overall increase is 40%. This rising plastic surgeries boosts the demand for IV cannulas.

Risk of infections and complications

The risk of infections and complications associated with the use of IV cannulas is a significant factor hampering the growth of the IV cannula market. Infections and other complications can lead to severe health issues, prolonged hospital stays, and increased medical costs, which can reduce patient satisfaction and undermine the effectiveness of IV therapies.

One of the major concerns with IV cannula use is the risk of hospital-acquired infections (HAIs), particularly bloodstream infections (BSIs) and local site infections. These infections are typically caused by improper insertion, lack of hygiene or prolonged use of the cannula, leading to complications such as phlebitis or sepsis.

For instance, according to Agency for Healthcare Research and Quality, central-line-associated bloodstream infections (CLABSIs) are among the most common types of HAIs, with approximately 28,000 cases reported annually in the U.S. These infections can result from the use of intravenous catheters, contributing to the hesitancy in using IV cannulas and slowing market growth.

Inflammation of the vein due to irritation caused by the cannula can lead to pain, swelling, and sometimes infection. Infiltration, where the IV fluid leaks into the surrounding tissue instead of entering the bloodstream, is another significant complication. Healthcare workers are at risk of needle-stick injuries when inserting, manipulating, or removing IV cannulas, especially in high-risk environments. These injuries can lead to exposure to bloodborne pathogens such as HIV, Hepatitis B and Hepatitis C.

For instance, according to Centers for Disease Control and Prevention (CDC), approximately 385,000 needle-stick injuries and other sharps-related injuries occur annually in U.S. hospitals, many involving IV cannulas. This raises concerns about the safety of healthcare workers and patients, influencing the demand for safer IV cannulas with built-in protective features.

Segment Analysis

The global IV cannula market is segmented based on product type, gauge size, material, application, end-user and region.

Product Type:

The peripheral IV cannula segment is expected to dominate the IV cannula market share

Peripheral IV cannulas are primarily used for fluid infusion, medication administration, blood transfusions and anesthesia in patients requiring short-term intravenous access. They are particularly common in emergency departments, pediatric care and surgical units. For instance, the American Society of Anesthesiologists (ASA) reports that over 40 to 50 million surgeries are performed annually in the U.S., with peripheral IV cannulas being used in a majority of these procedures for anesthesia and fluid administration.

Peripheral IV cannulas are typically used for short-term intravenous access (generally up to 72 hours) and can be quickly inserted into peripheral veins, such as those in the arm, hand, or forearm. The ease of insertion makes them ideal for emergency situations and routine clinical procedures. According to a study in the Journal of Infusion Nursing, peripheral IV cannulas are used in approximately 75-80% of all hospital admissions for intravenous therapy, largely due to their simplicity, speed, and effectiveness.

Geographical Analysis

North America is expected to hold a significant position in the IV cannula market share

The high prevalence of surgeries in North America, driven by the aging population and the widespread use of medical technologies, directly boosts the demand for IV cannulas. These procedures require intravenous access for medications, fluids, and anesthesia. The National Institute of Health (NIH) reports that more than 40 million surgeries are performed annually in the U.S., most of which involve the use of IV cannulas for intravenous access during procedures.

In North America, there is a growing focus on patient safety and the prevention of healthcare-associated infections (HAIs), which drives demand for safer IV cannulas. This includes the adoption of safety features in IV cannulas, such as shielded needles, antimicrobial coatings and advanced insertion technology. The demand for safer IV cannulas in North America is accelerating due to an increased focus on preventing needle-stick injuries and hospital-acquired infections (HAIs).

Asia-Pacific is growing at the fastest pace in the IV cannula market

Several countries in the APAC region, such as India, China, and Southeast Asia, are experiencing rapid growth in their healthcare infrastructure. Governments and private sectors are investing in medical facilities, hospitals, and clinics to meet the needs of a growing and aging population, which directly contributes to the demand for medical devices, including IV cannulas.

For instance, the Indian government has introduced initiatives like the Ayushman Bharat program, which aims to provide healthcare access to over 500 million people. This program has led to increased healthcare investments, directly boosting demand for medical devices such as IV cannulas.

The rise in medical tourism in countries such as India, Thailand, and Singapore contributing to the demand for advanced medical devices like IV cannulas. Medical tourists often seek affordable and high-quality medical treatments, including surgeries, which require intravenous therapies, driving the market for IV cannulas. For instance, India is one of the world's top destinations for medical tourism, with over 5 million medical tourists visiting annually for treatments like cardiac surgery, orthopedic surgeries, and cosmetic surgeries, all of which require intravenous access.

Competitive Landscape

The major global players in the IV cannula market include Becton, Dickinson and Company, Nipro Corporation, Romsons Scientific & Surgical Pvt. Ltd., Medtronic plc, Cruzine, MRK Healthcare Pvt. Ltd., Bio Med Healthcare Products Pvt Ltd, AdvaCare Pharma, iLife Medical Devices Pvt Ltd, Neotec Medical and among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global IV cannula market report delivers a detailed analysis with 78 key tables, more than 83 visually impactful figures, and 179 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.